Cancer BiologybioRxivPreprint
Acute resistance to BET inhibitors remodels compensatory transcriptional programs via p300 co-activation
V. Shah, G. Giotopoulos, H. Osaki…·D. Sasca
This study identifies p300-mediated compensatory transcriptional programs that drive acute resistance to BET inhibitors in AML and suggests sequential BET- and p300-inhibition as a therapeutic strategy.
DOI 10.1101/2022.09.14.507850